IRHYTHM INVESTOR ALERT: Kirby McInerney LLP Notifies iRhythm Technologies, Inc. (IRTC) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
Investors have until April 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- Investors have until April 8, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- The lawsuit alleges that, throughout the Class Period, iRhythm failed to disclose serious issues with its Zio AT heart monitor to the FDA, patients, or investors.
- As a result of these representations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.
- Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.